An investigative look at the systems that shape—and sometimes fail—modern healthcare.
A System in Crisis
American healthcare represents one of the great paradoxes of our time. We spend more per capita than any nation on earth, yet rank poorly on nearly every health outcome metric. We have the world's most advanced medical technology, yet chronic disease rates continue to climb.
Understanding why requires looking beyond the talking points and examining the structural incentives that shape the system.
Healthcare in America is not primarily a health system—it's an economic system.
Follow the Economics
Healthcare in America is not primarily a health system—it's an economic system. Hospitals are businesses. Insurance companies are businesses. Pharmaceutical companies are publicly traded corporations with fiduciary duties to shareholders.
None of this is inherently wrong. But it creates incentives that don't always align with patient outcomes. When revenue comes from treating disease rather than preventing it, where does the financial motivation for prevention come from?
The Insurance Paradox
Health insurance was designed to protect against catastrophic costs. Over time, it evolved into something different—a payment mechanism for routine care. This transformation has consequences.
When a third party pays, neither patient nor provider has strong incentives to control costs. Prices become detached from value. And the administrative complexity required to manage this system consumes resources that could otherwise fund care.
Pharmaceutical Realities
Drug development is expensive and risky. The pharmaceutical industry argues, with some justification, that high prices are necessary to fund innovation. But this argument deserves scrutiny.
Much basic research is publicly funded. Marketing budgets often exceed R&D budgets. The industry's practices don't always match its rhetoric.
Much basic research is publicly funded. Marketing budgets often exceed R&D budgets. Patent strategies sometimes prioritize extending monopolies over developing new treatments. The industry's practices don't always match its rhetoric.
The Regulatory Maze
Healthcare is among the most heavily regulated industries in America. These regulations serve legitimate purposes—patient safety, quality assurance, fraud prevention. But they also create barriers to entry, protect incumbent interests, and add costs that ultimately fall on patients.
Finding the right balance between protection and innovation is genuinely difficult. But we should acknowledge that current regulations don't always serve patients' interests as much as they serve the interests of existing healthcare institutions.
What Would Actually Work
Real reform would require aligning incentives with outcomes. Paying for health rather than procedures. Empowering patients with information and choices. Creating competition that drives value rather than volume.
It would also require honesty—acknowledging that the current system serves many powerful interests, and that meaningful change will face powerful opposition.
The Path Forward
I'm not waiting for the system to reform itself. At Kure Health, we're building an alternative that demonstrates what's possible when patient outcomes are the actual priority. It's a small start, but every revolution begins somewhere.
The healthcare industry needs critical analysis. It needs people willing to ask uncomfortable questions. It needs alternatives that prove better approaches are possible. Consider this my contribution to that necessary conversation.
With purpose,
Written by
Kenton Gray
Healthcare visionary, veteran, and author. Founder of Veracor Group and architect of Signal-Based Medicine.